drugset / Trial / NCT01038427

A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

NCT01038427

Phase 3 Completed 795 enrolled Sandoz
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study compared the efficacy and safety of a generic mometasone nasal spray to the reference listed drug in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations were tested for superiority against a placebo nasal spray.

Timeline

Start
2009-12-02
Primary completion
2010-02-16
Completion
2010-02-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 200 ug Intranasal